| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 18 |
| 1 | PREDNISOLONE ORAL | 18 |
| 2 | PREDNISOLONE ORAL SOLUTION | 18 |
| 3 | METHOTREXATE SODIUM | 17 |
| 4 | TACROLIMUS | 17 |
| 5 | METHOTREXATE | 16 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 15 |
| 7 | TACROLIMUS OINTMENT 0.1% | 15 |
| 8 | DEXAMETHASONE | 14 |
| 9 | DEXAMETHASONE 1.5 MG | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | 1 | 0.0025 |
| 1 | NADOFARAGENE FIRADENOVEC-VNCG | 1 | 0.0019 |
| 2 | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | 1 | 0.0012 |
| 3 | MARIBAVIR | 3 | 0.0012 |
| 4 | BARICITINIB | 3 | 0.0010 |
| 5 | DAPTOMYCIN | 6 | 0.0006 |
| 6 | ANIDULAFUNGIN | 1 | 0.0006 |
| 7 | DEFIBROTIDE SODIUM | 2 | 0.0006 |
| 8 | BLEOMYCIN SULFATE | 5 | 0.0005 |
| 9 | VASOPRESSIN | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 40 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 17 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 15 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 13 |
| 5 | Benzodiazepine [EPC] | 12 |
| 6 | Platinum-based Drug [EPC] | 12 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 8 | Azole Antifungal [EPC] | 10 |
| 9 | Calcium Channel Blocker [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 3 | 0.0012 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 2 | Lipopeptide Antibacterial [EPC] | 6 | 0.0006 |
| 3 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 4 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |
| 6 | Oxazolidinone Antibacterial [EPC] | 6 | 0.0002 |
| 7 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 4 | 0.0002 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |